High Prevalence of CAM Use Among Thyroid Cancer Patients

Among patients with thyroid cancer, use of complementary and alternative medicine is common, with more than 80% reporting use. These results were presented at the 14th International Thyroid Congress. Complementary and alternative medicines are therapies other than conventional medical treatment. Complementary medicine involves therapies most often used to supplement conventional medical treatments, whereas alternative medicine [...]

Combination of Herceptin® with Non–anthracycline-based Chemotherapy Appears to Be Effective

Among women with early, HER2-positive breast cancer, the addition of Herceptin® (trastuzumab) to adjuvant chemotherapy reduces the risk of cancer recurrence and improves survival. Herceptin provides a benefit in combination with either anthracycline- or non–anthracycline-based chemotherapy regimens. These results were presented at the 2009 San Antonio Breast Cancer Symposium. Twenty to 25 percent of breast [...]